Literature DB >> 9460645

Regulation of glucose transporters and hexose uptake in 3T3-L1 adipocytes: glucagon-like peptide-1 and insulin interactions.

Y Wang1, H K Kole, C Montrose-Rafizadeh, R Perfetti, M Bernier, J M Egan.   

Abstract

Glucagon-like peptide-1 (7-36 amide) (GLP-1) is known to increase insulin release when given as a bolus in the fasted and fed state. GLP-1 also increases glucose uptake and lipid synthesis in cultured adipocytes. In this study we investigated the effects of GLP-1 on glucose uptake and on the levels of expression of the facilitative glucose transporters, GLUT1 and GLUT4, in fully differentiated 3T3-L1 adipocytes. Cells were incubated with GLP-1 (10 nM) with or without insulin (10 and 100 nM) for 24 h. Under these conditions, GLP-1 alone caused an increase in basal and acute insulin-stimulated glucose uptake along with an increase in GLUT1 and GLUT4 protein levels. However, there was no change in the expression of GLUT1 and GLUT4 mRNAs. In the absence of GLP-1, prolonged exposure to insulin caused a marked reduction in the levels of GLUT4 mRNA and protein, and an inhibition of glucose uptake after an acute exposure to insulin. This insulin-induced down-regulation of GLUT4 was prevented when GLP-1 was present during the 24-h treatment. In contrast, the acute insulin-stimulated glucose uptake could not be restored by GLP-1. GLP-1 is therefore the first gut hormone shown to be capable of modulating glucose transporter levels in cultured adipocytes.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9460645     DOI: 10.1677/jme.0.0190241

Source DB:  PubMed          Journal:  J Mol Endocrinol        ISSN: 0952-5041            Impact factor:   5.098


  13 in total

Review 1.  Multifactorial intervention in Type 2 diabetes: the promise of incretin-based therapies.

Authors:  F Giorgino; A Leonardini; A Natalicchio; L Laviola
Journal:  J Endocrinol Invest       Date:  2011-01-13       Impact factor: 4.256

2.  Effect of GLP-1 treatment on GLUT2 and GLUT4 expression in type 1 and type 2 rat diabetic models.

Authors:  M L Villanueva-Peñacarrillo; J Puente; A Redondo; F Clemente; I Valverde
Journal:  Endocrine       Date:  2001-07       Impact factor: 3.633

Review 3.  Molecular mechanisms underlying physiological and receptor pleiotropic effects mediated by GLP-1R activation.

Authors:  K Pabreja; M A Mohd; C Koole; D Wootten; S G B Furness
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739

4.  Insulin secretion-independent effects of GLP-1 on canine liver glucose metabolism do not involve portal vein GLP-1 receptors.

Authors:  Dominique Dardevet; Mary Courtney Moore; Catherine A DiCostanzo; Ben Farmer; Doss W Neal; Wanda Snead; Margaret Lautz; Alan D Cherrington
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2005-07-28       Impact factor: 4.052

Review 5.  The role of incretins in glucose homeostasis and diabetes treatment.

Authors:  Wook Kim; Josephine M Egan
Journal:  Pharmacol Rev       Date:  2008-12-12       Impact factor: 25.468

6.  GLP-1 amplifies insulin signaling by up-regulation of IRbeta, IRS-1 and Glut4 in 3T3-L1 adipocytes.

Authors:  Hong Gao; Xinjun Wang; Zhiguo Zhang; Yisheng Yang; Jun Yang; Xiaoying Li; Guang Ning
Journal:  Endocrine       Date:  2007-10-02       Impact factor: 3.633

7.  Direct effect of GLP-1 infusion on endogenous glucose production in humans.

Authors:  M Seghieri; E Rebelos; A Gastaldelli; B D Astiarraga; A Casolaro; E Barsotti; A Pocai; M Nauck; E Muscelli; E Ferrannini
Journal:  Diabetologia       Date:  2012-10-12       Impact factor: 10.122

Review 8.  Identification and characterization of adipose surface epitopes.

Authors:  Yasuhiro Onogi; Ahmed Elagamy Mohamed Mahmoud Khalil; Siegfried Ussar
Journal:  Biochem J       Date:  2020-07-17       Impact factor: 3.857

9.  Exendin-4 Improves Nonalcoholic Fatty Liver Disease by Regulating Glucose Transporter 4 Expression in ob/ob Mice.

Authors:  Seok Kim; Jaehoon Jung; Hwajin Kim; Rok Won Heo; Chin-Ok Yi; Jung Eun Lee; Byeong Tak Jeon; Won-Ho Kim; Jong Ryeal Hahm; Gu Seob Roh
Journal:  Korean J Physiol Pharmacol       Date:  2014-08-13       Impact factor: 2.016

Review 10.  Recent advances in understanding the role of glucagon-like peptide 1.

Authors:  Josh Reed; Stephen Bain; Venkateswarlu Kanamarlapudi
Journal:  F1000Res       Date:  2020-04-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.